New sedation drug ciprofol tested against propofol for safer anesthesia in seniors

NCT ID NCT07670923

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares ciprofol and propofol, two drugs used to sedate elderly patients (ages 65-80) during short medical procedures without a breathing tube. Researchers will monitor heart rate, blood pressure, and breathing for 5 minutes after giving the drug. The goal is to see which drug causes fewer side effects on the heart and lungs. 108 participants will be enrolled at a single hospital in China.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ciprofol and propofol

What this could lead to

If ciprofol proves safer for heart and lung function, it could become a preferred sedation option for elderly patients undergoing short procedures.

What could go wrong

This is a small, early-phase trial (108 participants) comparing two drugs, so results may not apply broadly. Both drugs carry risks like low blood pressure or breathing problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPARISON OF HEMODYNAMICS AND RESPIRATORY FUNCTION BETWEEN CIPROFOL AND PROPOFOL IN ELDERLY PATIENTS UNDERGOING NON-INTUBATED GENERAL ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Respiratory Aspiration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cardiovascular and Cerebrovascular Disease Hospital, General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, 750000, China